Snapshot from Jul 04, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / BlackThorn Therapeutics
Entity

BlackThorn Therapeutics

Tracked across 2 events · 62 articles · First seen Feb 06, 2025 · Last active Apr 06, 2025

Sentiment
-5
Attention
4
Events
2
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
2 0
Business
Neumora Therapeutics IPO Class Action
Impact: BlackThorn Therapeutics' original Phase Two Trial inclusion criteria were allegedly amended by Neumora Therapeutics to justify its Phase Three Program, which is a key point in the class action lawsuit.
Feb 07, 2025 · 6 articles
4 -10
Business
Neumora Therapeutics Securities Class Action
Impact: BlackThorn Therapeutics' original Phase Two trial inclusion criteria were allegedly amended by Neumora Therapeutics to justify its Phase Three Program for Navacaprant.
Feb 11, 2025 · 56 articles
Relationships (2)
Neumora Therapeutics target ↔ BlackThorn Therapeutics BlackThorn Therapeutics was acquired by Neumora Therapeutics in September 2020,
Neumora Therapeutics acquirer ↔ BlackThorn Therapeutics Neumora Therapeutics acquired BlackThorn Therapeutics in September 2020, integra
NEWSDESK
Track BlackThorn Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.